Alpha memo: activated mortality severe endpoint split

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Resolve the core identity problem: either identify a genuine shared research signal between APTT prognostic modeling in SFTS and APC mechanisms in sepsis, or drop one receipt and reframe as a single-receipt memo with a clear, bounded claim.
2. Define a specific research question that the memo answers (e.g., 'Does APTT-based prognostic modeling in SFTS align with APC-pathway mechanisms identified in severe sepsis models?') or reframe as a single-anchor memo on APTT mortality prediction in SFTS.
3. If the two-receipt structure is retained, provide an explicit analytic bridge (shared pathway, shared biomarker logic, or mechanistic hypothesis) rather than a keyword match on 'activated' and 'mortality.'
4. Correct the domain slug to reflect actual content (infectious disease / coagulation / critical care).
5. State concrete, actionable next steps rather than the generic 'falsify with a direct replication' falsifier.

Major issues

• The title and 'alpha' frame a 'bounded population/endpoint split' over `activated, mortality, severe` but the two receipts are fundamentally unrelated: Receipt 1 is about APTT (a coagulation lab value) predicting mortality in SFTS (a tick-borne viral disease); Receipt 2 is about recombinant APC treatment in murine endotoxemia/sepsis models and its mechanisms (EPCR/PAR-1). The only lexical overlap is the word 'activated' and 'mortality' — APTT ≠ APC. This is a keyword-matched pseudo-connection, not a substantive research signal.
• No coherent research question is posed. The memo does not articulate what the 'split' actually claims — it is a forced contrast between two papers that study different molecules, different diseases, different species, and different endpoints.
• The synthesis is empty: the body simply restates the two receipt findings side by side without any integration, shared framework, or argument for why they belong together. The 'Why this is surprising' section restates the same two findings verbatim without adding analytic value.
• The domain_slug 'cardiometabolic_research' is mismatched with the actual content (SFTS virology / sepsis coagulation biology), suggesting automated or careless categorization.

Minor issues

• The title 'activated mortality severe endpoint split' is opaque and does not communicate a recognizable research signal.
• Receipt 2 is a 2006 conference abstract (Blood supplement) and is old relative to current sepsis literature; its relevance as a current signal is not discussed.
• The memo does not specify what 'falsification with a direct replication' would look like in practice, since the two studies cannot be directly replicated under one protocol given their disparate designs.

Reviewer note

This memo fails the basic alpha-memo requirement of making one bounded, source-grounded research signal clear. Receipt 1 concerns APTT (activated partial thromboplastin time, a coagulation assay) as a prognostic biomarker for mortality in SFTS patients in north China. Receipt 2 concerns recombinant activated protein C (APC, a completely different molecule) and its mechanism of mortality reduction in murine endotoxemia and bacterial sepsis models. APTT and APC share the lexical token 'activated' but are otherwise unrelated — one is a lab measurement, the other is a therapeutic agent. The memo constructs a 'population/endpoint split' framing from this superficial lexical overlap without any substantive integration. The body is a near-verbatim restatement of the two abstracts with no synthesis, no shared framework, and no falsifiable claim. The caveats/falsifiers section does not rescue this because the underlying premise — that these two papers share a research signal — is itself the problem. The domain slug 'cardiometabolic_research' is also mismatched with the virology/sepsis content. This is a structurally broken memo whose central claim (a meaningful split between these two receipts) is not supported, and bounded edits cannot fix the identity problem — it needs a scope reset, either as a single-receipt memo on APTT mortality prediction in SFTS or as a properly bridged two-receipt memo with a genuine mechanistic connection.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis